rdf:type |
|
lifeskim:mentions |
umls-concept:C0007137,
umls-concept:C0008838,
umls-concept:C0030705,
umls-concept:C0032790,
umls-concept:C0144576,
umls-concept:C0205420,
umls-concept:C0282460,
umls-concept:C0332283,
umls-concept:C0460004,
umls-concept:C0684224,
umls-concept:C1514695,
umls-concept:C1521996,
umls-concept:C1522449
|
pubmed:issue |
28
|
pubmed:dateCreated |
2009-9-30
|
pubmed:databankReference |
|
pubmed:abstractText |
We sought to improve outcomes for patients with high-risk head and neck squamous cell cancer (HNSCC) after surgical resection by testing the feasibility and safety of early postoperative chemotherapy followed by concurrent chemoradiotherapy.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1527-7755
|
pubmed:author |
pubmed-author:AngK KianKK,
pubmed-author:ForastiereArlene AAA,
pubmed-author:GardenAdam SAS,
pubmed-author:HarrisJonathanJ,
pubmed-author:KuettelMichael RMR,
pubmed-author:MyersJeffrey NJN,
pubmed-author:RidgeJohn AJA,
pubmed-author:RosenthalDavid IDI,
pubmed-author:SchultzChristopher JCJ,
pubmed-author:SidhuKulbirK,
pubmed-author:TrottiAndyA,
pubmed-author:WeberRandal SRS
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4727-32
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19720915-Adult,
pubmed-meshheading:19720915-Aged,
pubmed-meshheading:19720915-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19720915-Carcinoma, Squamous Cell,
pubmed-meshheading:19720915-Cisplatin,
pubmed-meshheading:19720915-Combined Modality Therapy,
pubmed-meshheading:19720915-Feasibility Studies,
pubmed-meshheading:19720915-Female,
pubmed-meshheading:19720915-Follow-Up Studies,
pubmed-meshheading:19720915-Head and Neck Neoplasms,
pubmed-meshheading:19720915-Humans,
pubmed-meshheading:19720915-Kaplan-Meier Estimate,
pubmed-meshheading:19720915-Male,
pubmed-meshheading:19720915-Middle Aged,
pubmed-meshheading:19720915-Paclitaxel,
pubmed-meshheading:19720915-Radiotherapy,
pubmed-meshheading:19720915-Skin Diseases,
pubmed-meshheading:19720915-Time Factors,
pubmed-meshheading:19720915-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024.
|
pubmed:affiliation |
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. dirosenthal@mdanderson.org
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II,
Research Support, N.I.H., Extramural
|